Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
FDA Grants Priority Review for Leqembi Iqlik Subcutaneous Dose
BioArctic AB’s partner Eisai announced that the U.S. Food and Drug Administration has granted Priority Review for the supplemental Biologics License Application for Leqembi Iqlik, a subcutaneous autoinjector designed as a weekly starting dose for patients with early-stage Alzheimer’s disease. The Prescription Drug User Fee Act action date for the review is set for May 24, 2026. If approved, Leqembi Iqlik would become the first anti-amyloid therapy offering patients the option to start and maintain treatment at home through subcutaneous administration instead of the current bi-weekly intravenous infusion.
Travis Palmquist Joins Lifespark as Chief Growth Officer
Travis Palmquist, a senior care executive with more than 35 years of experience in senior living, has joined Lifespark, a full-service senior health company, as Chief Growth Officer. Palmquist brings extensive knowledge in senior living operations, skilled nursing, long-term and post-acute care technology, business development, and organizational growth.
PracticeQ Launches Engage to Reduce No Shows with Automation
PracticeQ has introduced Engage, a patient engagement platform designed to address one of the most persistent challenges in healthcare operations: missed appointments. Engage combines automated reminders, recall workflows, review requests, and secure messaging into a single integrated system that helps practices maintain patient connections and keep schedules on track.
LEO Pharma Showcases 23 Posters at Maui Derm Hawaii 2026
LEO Pharma A S, a global company focused on medical dermatology, announced that it will present 23 scientific posters at Maui Derm Hawaii 2026, taking place from January 25 to 29. The presentations highlight a broad range of evidence across multiple dermatologic conditions, including atopic dermatitis, chronic hand eczema, generalized pustular psoriasis, and pyoderma gangrenosum. The posters feature clinical trial findings, real world data, and U S focused analyses that reflect the company’s continued investment in advancing dermatology research.
MedeAnalytics Appoints David Figueredo as Chief Innovation Officer
MedeAnalytics, a healthcare enterprise data enrichment platform and analytics SaaS company, has announced the appointment of David Figueredo as its new Chief Innovation Officer. With more than two decades of experience across healthcare technology, operations, and innovation, Figueredo steps into the role with a strong track record of turning complex healthcare challenges into practical, AI-enabled solutions that drive growth and measurable results.
To share your insights, please write to us at sudipto@intentamplify.com
